Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases

MeSH terms

• Adalimumab
• Aged
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antirheumatic Agents / adverse effects
• Antirheumatic Agents / therapeutic use
• Arthritis, Rheumatoid / complications*
• Arthritis, Rheumatoid / drug therapy
• Female
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use
• Leishmaniasis, Visceral / diagnosis*
• Leishmaniasis, Visceral / epidemiology*
• Methotrexate / adverse effects
• Methotrexate / therapeutic use
• Opportunistic Infections / diagnosis*
• Opportunistic Infections / epidemiology*
• Prevalence
• Risk Factors